Featured Research

from universities, journals, and other organizations

Eye floaters and flashes of light linked to retinal tear, detachment

Date:
November 25, 2009
Source:
Queen's University
Summary:
Suddenly seeing floaters or flashes of light may indicate a serious eye problem that -- if untreated -- could lead to blindness, a new study shows.

Suddenly seeing floaters or flashes of light may indicate a serious eye problem that -- if untreated -- could lead to blindness, a new study shows.

Researchers from Queen's University and Hotel Dieu Hospital in Kingston have discovered that one in seven patients with this symptom will have a retinal tear or detachment.

"If we detect a tear and laser it, we can save people from potentially going blind," says senior author of the study Dr. Sanjay Sharma, a professor of Ophthalmology and Epidemiology at Queen's and head of the Unit for Cost-Effective Ocular Health Policy at HDH. "But if fluid gets in under the retina and causes it to detach, it may be too late."

Because retinal tears can be extremely difficult to see, high-tech equipment and a thorough peripheral retinal examination are required to detect them, he adds.

The research, to be published online Nov. 24 in the Journal of the American Medical Association, is partially funded by the Canadian Institutes of Health Research.

To perform their study, the team analyzed nearly 200 articles published in the peer-reviewed literature. They then performed a meta-analysis of 17 articles, and noted that a retinal tear occurred in 14 per cent of the cases of new onset floaters associated with an age-related change in the eye's jelly.

"If new floaters are associated with visual loss, a defect in the visual field, or the presence of blood or 'tobacco dust' in the eye jelly, the risk of retinal tear is significantly higher," says Dr. Sharma. "Since retinal tear can lead to detachment in up to 50 per cent of cases, new floaters and flashes is a medical condition that needs urgent assessment."

Also on the team, from Queen's and Hotel Dieu Hospital, are Drs. Hussein Hollands, Anya Brox, David Almeida, and research assistant Davin Johnson. Dr. David Simel is from Duke University.


Story Source:

The above story is based on materials provided by Queen's University. Note: Materials may be edited for content and length.


Cite This Page:

Queen's University. "Eye floaters and flashes of light linked to retinal tear, detachment." ScienceDaily. ScienceDaily, 25 November 2009. <www.sciencedaily.com/releases/2009/11/091124174618.htm>.
Queen's University. (2009, November 25). Eye floaters and flashes of light linked to retinal tear, detachment. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/11/091124174618.htm
Queen's University. "Eye floaters and flashes of light linked to retinal tear, detachment." ScienceDaily. www.sciencedaily.com/releases/2009/11/091124174618.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins